1
|
Purohit S, Girisa S, Ochiai Y, Kunnumakkara AB, Sahoo L, Yanase E, Goud VV. Scirpusin B isolated from Passiflora edulis Var. flavicarpa attenuates carbohydrate digestive enzymes, pathogenic bacteria and oral squamous cell carcinoma. 3 Biotech 2024; 14:28. [PMID: 38173823 PMCID: PMC10758380 DOI: 10.1007/s13205-023-03876-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/19/2022] [Accepted: 12/04/2023] [Indexed: 01/05/2024] Open
Abstract
Passiflora edulis Var. flavicarpa (passion fruit) generates vast waste (60-70%) in the form of peel and seed after the juice extraction. The study aimed to isolate Scirpusin B (SB) from passion fruit (PF) seed waste collected from Northeast India and to analyse its anti-radical, antibacterial, anti-diabetic, and anti-oral cancer activities. Scirpusin B was isolated following hydro-alcoholic extraction, fractionation, and column chromatography. The isolated fraction was further identified through NMR and mass spectroscopy. SB exhibited significant antiradical activity against six standard antioxidant compounds, indicating its commercial application. SB inhibited α-amylase (IC50 Value: 76.38 ± 0.25 µg/mL) and α-glucosidase digestive enzymes (IC50 Value: 2.32 ± 0.04 µg/mL), signifying its antidiabetic properties. In addition, SB showed profound antibacterial activity against eight gram-positive and gram-negative bacteria reported for the first time. Furthermore, SB inhibited SAS and TTN oral cancer cell proliferation up to 95% and 83%, respectively. SB significantly inhibited colonies of SAS and TTn cells in the clonogenic assay, attributing to its anticancer properties. The PI-FACS assay confirmed the ability of SB (75 µM) to kill SAS and TTn cells by 40.26 and 44.3% in 72 h. The mechanism of SB inhibiting oral cancer cell proliferation was understood through western blot analysis, where SB significantly suppressed different cancer hallmark proteins, such as TNF-α, survivin, COX-2, cyclin D1, and VEGF-A. The present study suggests that SB isolated from PF seed can add noteworthy value to the waste biomass for various industrial and medical applications. Supplementary Information The online version contains supplementary material available at 10.1007/s13205-023-03876-6.
Collapse
Affiliation(s)
- Sukumar Purohit
- School of Energy Science and Engineering, Indian Institute of Technology, Guwahati, India
- Faculty of Applied Biological Sciences, Gifu University, Gifu, Japan
| | - Sosmitha Girisa
- Department of Biosciences and Bioengineering, Indian Institute of Technology, Guwahati, India
| | - Yuto Ochiai
- Faculty of Applied Biological Sciences, Gifu University, Gifu, Japan
| | | | - Lingaraj Sahoo
- School of Energy Science and Engineering, Indian Institute of Technology, Guwahati, India
- Department of Biosciences and Bioengineering, Indian Institute of Technology, Guwahati, India
| | - Emiko Yanase
- Faculty of Applied Biological Sciences, Gifu University, Gifu, Japan
| | - Vaibhav V. Goud
- School of Energy Science and Engineering, Indian Institute of Technology, Guwahati, India
- Department of Chemical Engineering, Indian Institute of Technology, Guwahati, India
| |
Collapse
|
2
|
Fiore M, Minni A, Cavalcanti L, Raponi G, Puggioni G, Mattia A, Gariglio S, Colizza A, Meliante PG, Zoccali F, Tarani L, Barbato C, Lucarelli M, Ceci FM, Francati S, Ferraguti G, Ceccanti M, Petrella C. The Impact of Alcohol Consumption and Oral Microbiota on Upper Aerodigestive Tract Carcinomas: A Pilot Study. Antioxidants (Basel) 2023; 12:1233. [PMID: 37371963 DOI: 10.3390/antiox12061233] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/15/2023] [Revised: 05/29/2023] [Accepted: 06/05/2023] [Indexed: 06/29/2023] Open
Abstract
Alcohol consumption is associated with oxidative stress and an increased risk of carcinoma of the upper aero-digestive tract (UADT). Recently, it has been found that some microorganisms in the human oral cavity may locally metabolize ethanol, forming acetaldehyde, a carcinogenic metabolite of alcohol. In a cohort of patients first visited for UADT cancers, we estimated their alcohol consumption by measuring Ethyl Glucuronide/EtG (a long-lasting metabolite of ethanol) in the hair and carbohydrate-deficient transferrin/CDT (short-term index of alcohol intake) in the serum. Moreover, we analyzed, by culture-based methods, the presence of Neisseria subflava, Streptococcus mitis, Candida albicans, and glabrata (microorganisms generating acetaldehyde) in the oral cavity. According to the EtG values, we correlated drinking alcohol with endogenous oxidative stress and the investigated microorganism's presence. We found that 55% of heavy drinkers presented microorganisms generating acetaldehyde locally. Moreover, we found that the presence of oral acetaldehyde-producing bacteria correlates with increased oxidative stress compared to patients without such bacteria. As for the study of alcohol dehydrogenase gene polymorphisms (the enzyme that transforms alcohol to acetaldehyde), we found that only the "CGTCGTCCC" haplotype was more frequent in the general population than in carcinoma patients. This pilot study suggests the importance of estimating alcohol consumption (EtG), the presence of bacteria producing acetaldehyde, and oxidative stress as risk factors for the onset of oral carcinomas.
Collapse
Affiliation(s)
- Marco Fiore
- Institute of Biochemistry and Cell Biology (IBBC-CNR), Sapienza University Hospital Policlinico Umberto I, 00161 Roma, Italy
| | - Antonio Minni
- Department of Sensory Organs, Sapienza University of Rome, 00161 Roma, Italy
- Division of Otolaryngology-Head and Neck Surgery, San Camillo de Lellis Hospital, ASL Rieti-Sapienza University, Viale Kennedy, 02100 Rieti, Italy
| | - Luca Cavalcanti
- Department of Sensory Organs, Sapienza University of Rome, 00161 Roma, Italy
| | - Giammarco Raponi
- Laboratory for Clinical Microbiology, Sapienza University Hospital Policlinico Umberto I, 00161 Roma, Italy
| | - Gianluca Puggioni
- Laboratory for Clinical Microbiology, Sapienza University Hospital Policlinico Umberto I, 00161 Roma, Italy
| | - Alessandro Mattia
- Dipartimento della Pubblica Sicurezza, Direzione Centrale di Sanità, Centro di Ricerche e Laboratorio di Tossicologia Forense, Ministero dell'Interno, 00185 Roma, Italy
| | - Sara Gariglio
- DIFAR-Department of Pharmacy, Università di Genova, Viale Cembrano 4, 16148 Genova, Italy
| | - Andrea Colizza
- Department of Sensory Organs, Sapienza University of Rome, 00161 Roma, Italy
| | | | - Federica Zoccali
- Department of Sensory Organs, Sapienza University of Rome, 00161 Roma, Italy
| | - Luigi Tarani
- Department of Maternal Infantile and Urological Sciences, Sapienza University of Rome, 00161 Roma, Italy
| | - Christian Barbato
- Institute of Biochemistry and Cell Biology (IBBC-CNR), Sapienza University Hospital Policlinico Umberto I, 00161 Roma, Italy
| | - Marco Lucarelli
- Department of Experimental Medicine, Sapienza University of Rome, 00161 Roma, Italy
- Pasteur Institute Cenci Bolognetti Foundation, Sapienza University of Rome, 00161 Roma, Italy
| | - Flavio Maria Ceci
- Department of Experimental Medicine, Sapienza University of Rome, 00161 Roma, Italy
| | - Silvia Francati
- Department of Experimental Medicine, Sapienza University of Rome, 00161 Roma, Italy
| | - Giampiero Ferraguti
- Department of Experimental Medicine, Sapienza University of Rome, 00161 Roma, Italy
| | - Mauro Ceccanti
- ASL Roma1, SITAC, Società Italiana per il Trattamento dell'Alcolismo e le sue Complicanze, 00100 Roma, Italy
| | - Carla Petrella
- Institute of Biochemistry and Cell Biology (IBBC-CNR), Sapienza University Hospital Policlinico Umberto I, 00161 Roma, Italy
| |
Collapse
|
3
|
El-Naggar MH, Abdel Bar FM, Harsha C, Monisha J, Shimizu K, Kunnumakkara AB, Badria FA. Synthesis of new selective cytotoxic ricinine analogues against oral squamous cell carcinoma. Nat Prod Res 2019; 35:2145-2156. [PMID: 31526148 DOI: 10.1080/14786419.2019.1663513] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
Sixteen new analogues were synthesized from ricinine and tested alongside with seven known analogues for their cytotoxic activity against oral cancer (SAS cells) and normal epithelial cells (L132 cells). In contrast to 5-FU, the synthesized ricinine analogues did not show toxicity to normal cells. However, some of them inhibited the proliferation of oral cancer cells at 25 µM as evident from the MTT assay results. Ricinine analogue (19) was shown to be the most active derivative (69.22% inhibition). Potential targets involved in the oral cancer inhibitory activity of compound 19 were investigated using in-silico studies and western blot analysis. PTP1B was predicted to be a target for ricinine using reverse docking approach. This prediction was confirmed by western blot analysis that revealed the downregulation of PTP1B protein by compound 19. Moreover, it showed downregulation of COX-2 which is also extensively expressed in oral cancer.
Collapse
Affiliation(s)
- Mai H El-Naggar
- Pharmacognosy Department, Faculty of Pharmacy, Mansoura University, Mansoura 35516 Egypt.,Pharmacognosy Department, Faculty of Pharmacy, Kafrelsheikh university, Kafrelsheikh, Egypt
| | - Fatma M Abdel Bar
- Pharmacognosy Department, Faculty of Pharmacy, Mansoura University, Mansoura 35516 Egypt.,Pharmacognosy Department, Faculty of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj 11942, Saudi Arabia
| | - Choudhary Harsha
- Laboratory of Cancer Biology and DBT-AIST International Laboratory for Advanced Biomedicine, Biosciences and Bioengineering Department, Indian Institute of Technology Guwahati, Assam, India
| | - Javadi Monisha
- Laboratory of Cancer Biology and DBT-AIST International Laboratory for Advanced Biomedicine, Biosciences and Bioengineering Department, Indian Institute of Technology Guwahati, Assam, India
| | - Kuniyoshi Shimizu
- Systematic Forest and Forest Products Sciences Division, Agro-Environmental Sciences Department, Bioresource and Bioenvironmental Sciences Graduate School, Kyushu University, Fukuoka, Japan
| | - Ajaikumar B Kunnumakkara
- Laboratory of Cancer Biology and DBT-AIST International Laboratory for Advanced Biomedicine, Biosciences and Bioengineering Department, Indian Institute of Technology Guwahati, Assam, India
| | - Farid A Badria
- Pharmacognosy Department, Faculty of Pharmacy, Mansoura University, Mansoura 35516 Egypt
| |
Collapse
|
4
|
Makhijani RK, Raut SA, Purohit HJ. Fold change based approach for identification of significant network markers in breast, lung and prostate cancer. IET Syst Biol 2018; 12:213-218. [PMID: 30259866 PMCID: PMC8687202 DOI: 10.1049/iet-syb.2018.0012] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/12/2018] [Revised: 04/12/2018] [Accepted: 04/15/2018] [Indexed: 12/17/2022] Open
Abstract
Cancer belongs to a class of highly aggressive diseases and a leading cause of death in the world. With more than 100 types of cancers, breast, lung and prostate cancer remain to be the most common types. To identify essential network markers (NMs) and therapeutic targets in these cancers, the authors present a novel approach which uses gene expression data from microarray and RNA-seq platforms and utilises the results from this data to evaluate protein-protein interaction (PPI) network. Differentially expressed genes (DEGs) are extracted from microarray data using three different statistical methods in R, to produce a consistent set of genes. Also, DEGs are extracted from RNA-seq data for the same three cancer types. DEG sets found to be common in both platforms are obtained at three fold change (FC) cut-off levels to accurately identify the level of change in expression of these genes in all three cancers. A cancer network is built using PPI data characterising gene sets at log-FC (LFC)>1, LFC>1.5 and LFC>2, and interconnection between principal hub nodes of these networks is observed. Resulting network of hubs at three FC levels highlights prime NMs with high confidence in multiple cancers as validated by Gene Ontology functional enrichment and maximal complete subgraphs from CFinder.
Collapse
Affiliation(s)
- Richa K Makhijani
- Department of Computer Science and Engineering, Visvesvaraya National Institute of Technology, Nagpur (MS) 440010, India.
| | - Shital A Raut
- Department of Computer Science and Engineering, Visvesvaraya National Institute of Technology, Nagpur (MS) 440010, India
| | - Hemant J Purohit
- Environmental Genomics Division, National Environmental Engineering Research Institute, Nagpur (MS) 440020, India
| |
Collapse
|
5
|
Makhijani RK, Raut SA, Purohit HJ. Identification of common key genes in breast, lung and prostate cancer and exploration of their heterogeneous expression. Oncol Lett 2017; 15:1680-1690. [PMID: 29434863 PMCID: PMC5776944 DOI: 10.3892/ol.2017.7508] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/08/2017] [Accepted: 10/20/2017] [Indexed: 12/12/2022] Open
Abstract
Cancer is one of the leading causes of mortality worldwide, and in particular, breast cancer in women, prostate cancer in men, and lung cancer in both women and men. The present study aimed to identify a common set of genes which may serve as indicators of important molecular and cellular processes in breast, prostate and lung cancer. Six microarray gene expression profile datasets [GSE45827, GSE48984, GSE19804, GSE10072, GSE55945 and GSE26910 (two datasets for each cancer)] and one RNA-Seq expression dataset (GSE62944 including all three cancer types), were downloaded from the Gene Expression Omnibus database. Differentially expressed genes (DEGs) were identified in each individual cancer type using the LIMMA statistical package in R, and then a comparison of the resulting gene lists was performed to identify common DEGs across cancer types. This analysis was performed for microarray and RNA-Seq datasets individually, revealing a set of 62 and 1,290 differentially expressed genes respectively, which may be associated with the three cancers. Out of these genes, 44 were common to both analyses, and hence termed key genes. Gene Ontology functional annotation, Kyoto Encyclopedia of Genes and Genomes pathway mapping and literature citations were used to confirm the role of the key genes in cancer. Finally, the heterogeneity of expression of the key genes was explored using the I2 statistic (meta package in R). The results demonstrated non-heterogeneous expression of 6 out of the 44 key genes, whereas the remaining genes exhibited significant heterogeneity in expression across microarray samples. In conclusion, the identified DEGs may play important roles in the pathogenesis of breast, prostate and lung cancer and may be used as biomarkers for the development of novel diagnostic and therapeutic strategies.
Collapse
Affiliation(s)
- Richa K Makhijani
- Department of Computer Science and Engineering, Visvesvaraya National Institute of Technology, Nagpur, Maharashtra 440010, India
| | - Shital A Raut
- Department of Computer Science and Engineering, Visvesvaraya National Institute of Technology, Nagpur, Maharashtra 440010, India
| | - Hemant J Purohit
- Environmental Genomics Division, National Environmental Engineering Research Institute, Nagpur, Maharashtra 440020, India
| |
Collapse
|